Medifron DBT Co. Ltd (065650) — Cash Flow-to-Debt Ratio
Medifron DBT Co. Ltd (065650) has a Cash Flow-to-Debt Ratio of -0.15x as of September 2025, meaning its operating cash flow of ₩-12.73 Billion could theoretically repay 0% of its total liabilities (₩86.61 Billion) in one year. Explore Medifron DBT Co. Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Medifron DBT Co. Ltd Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for Medifron DBT Co. Ltd across 11 annual periods. Also explore Medifron DBT Co. Ltd asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Medifron DBT Co. Ltd (2014–2024)
Year-by-year debt coverage analysis for Medifron DBT Co. Ltd. For market capitalisation and broader financial context, see 065650 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.11x | ₩-4.54 Billion | ₩42.92 Billion | ▲ +6.6% |
| 2023 | -0.11x | ₩-2.14 Billion | ₩18.89 Billion | ▲ +4.2% |
| 2022 | -0.12x | ₩-2.91 Billion | ₩24.66 Billion | ▲ +46.5% |
| 2021 | -0.22x | ₩-1.50 Billion | ₩6.81 Billion | ▼ -155.3% |
| 2020 | -0.09x | ₩-1.67 Billion | ₩19.36 Billion | ▲ +96.4% |
| 2019 | -2.42x | ₩-4.28 Billion | ₩1.77 Billion | ▼ -574.2% |
| 2018 | -0.36x | ₩-852.48 Million | ₩2.37 Billion | ▲ +54.2% |
| 2017 | -0.78x | ₩-1.17 Billion | ₩1.49 Billion | ▼ -48.2% |
| 2016 | -0.53x | ₩-1.15 Billion | ₩2.18 Billion | ▼ -2085.2% |
| 2015 | -0.02x | ₩-170.27 Million | ₩7.04 Billion | ▼ -5408.5% |
| 2014 | 0.00x | ₩701.96K | ₩1.54 Billion | — |